Method for multiple portal vein infusions in mice: Quantitation of adenovirus-mediated hepatic gene transfer

BioTechniques

Volumn 20, Issue 2, 1996, Pages 278-285

  Vrancken Peeters, Marie Jeanne T F D ^a   Lieber, Andre ^a   Perkins, James ^a   Kay, Mark A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULATION; CONTROLLED STUDY; FEMALE; GENE TRANSFER; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MOUSE; NONHUMAN; PERIPHERAL VEIN; PORTAL VEIN; TISSUE DISTRIBUTION; VASCULAR ACCESS; VIRUS GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0003234944     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/96202rr05     Document Type: Article

References (20)

1. Barr, D., J. Tubb, D. Ferguson, A. Lieber, A.J. Perkins and M. A. Kay. 1995. Strain related variations in adenovirally-mediated transgene expression in mouse hepatocytes in vivo, comparisons between immunocompetent and immunodeficient inbred strains Gene Ther 2:151-155.
2. Branchereau S., D. Calise and N. Ferry. 1994. Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo. Hum. Gene Ther. 5:803-808.
3. Chowdhury, J.R., M. Grossman, S. Gupta, N.R. Chowdhury, J.R. Baker and J.M. Wilson. 1991. Long-term improvement of hypercholesterolaemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 254:1802-1805.
4. Fang, B., R.C. Eisensmith, X.H.C. Li, M.J. Finegold, A. Shedlovsky, W. Dove and S.L.C. Woo. 1994. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther. 1:247-254.
5. Grossman, M., S.E. Raper, K. Kozarsky, E.A. Stein, J.F. Engelhardt, D. Muller, P.J. Lupien and J.M. Wilson. 1994. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat. Genet. 6:335-341.
6. Kay, M.A., P. Baley, S. Rothenberg, F. Leland, L. Fleming, K. Parker Ponder, T. Liu, M. Finegold, G. Darlington, W. Pokorny and S.L.C. Woo. 1992. Expresson of human α1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89:89-93
7. Kay M.A., F. Graham, F. Leland and S.L.C. Woo. 1995. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenovrial mediated gene transfer into mouse hepatocytes. Hepatology 21.815-819.
8. Kay, M.A., C.N. Landen, S. Rothenberg, L.A. Taylor, F. Leland, S. Wiehle, B. Fang, D. Bellinger, M. Finegold, A.R. Thompson, M. Reed, K.M. Brinkhous and S.L.C.Woo. 1994. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91:2353-2357.
9. Kay, M.A., Q. Li, T. Liu, F. Leland, C. Toman, M. Finegold and S.LC. Woo. 1992. Hepatic gene therapy, persistent expression of human α1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3:641-647.
10. Kay, M.A. and S.L.C. Woo. 1994. Gene therapy for metabolic disorders. Trends Genet. 10:253-257.
11. Li, Q., M.A. Kay, M. Finegold, L.D. Stratford-Perricaudet and S.L.C. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
12. Lieber, A., M.T.F.D. Vrancken Peeters, L. Meuse, N. Fausto, J. Perkins and M.A. Kay. 1995. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo Proc. Natl Acad. Sci. USA 92:6210-6214.
13. Ponder K., R. P. Dunbar, D.R. Wilson, G. Darlington and S.L.C Woo. 1991. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum. Gene Ther. 2:41-52.
14. Ponder, K., S. Gupta, F. Leland, G.Darlington, M. Finegold, J. DeMayo, F.D. Ledley, J.R. Chowdhury and S.L.C. Woo. 1991. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88:1217-1221.
15. Porteous, D.J. and J.R. Dorin. 1993. How relevant are mouse models for human disease to somatic gene therapy? Trends Biotechnol. 11:173-181.
16. Searle, P.E., B.L. Davison, G.W. Stuart, T.M. Wilkie, G. Norstedt and R.D. Palmiter. 1984. Regulation, linkage, and sequence of mouse metallothionein I and II genes. Mol. Cell. Biol 4:1221-1230.
17. Smith, T.A., M.G. Mehaffey, D.B. Kayda, J.M. Saunders, S. Yei, B.C. Trapnell, A. McClelland and M. Kaleko. 1993. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat. Genet. 5.397-402.
18. Stratford-Perricaudet, L.D., I. Makeh, M. Perricaudet and P. Briand. 1992. Wide-spread long-term gene transfer to mouse skeletal muscles and heart J. Clin. Invest. 90:626-630.
19. Webber, E.M., J.C. Wu, J.C. Wang, G. Merlino and N. Fausto. 1994. Overexpression of transforming growth factor alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am. J. Pathol. 145:398-408.
20. Yang, Y., H.C.J. Ertl and J.M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.